Manufacturers/Intra-Cellular Therapies, Inc

Intra-Cellular Therapies, Inc

3 drugs in NADAC|0 Generic,3 Brand

Intra-Cellular Therapies, Inc lists 3 NDCs in the CMS NADAC file (0 generic, 3 brand), at an average NADAC of $57.22 per unit, with a week-over-week move of +0.0% across products that moved. The firm's full portfolio, pricing trend are listed below.

Total Drugs

3

0G / 3B

Avg Price / Unit

$57.2228

$57.20 – $57.23

Avg 7d Change

+0.01%

Across 2 drugs with changes

7d Activity

1↑1↓1 flat

of 3 total drugs

Portfolio Price Trend

Monthly average NADAC price across all drugs

Keep following this manufacturer

These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.

Frequently Asked Questions

How many drugs does Intra-Cellular Therapies, Inc make?

Intra-Cellular Therapies, Inc lists 3 NDCs in the CMS NADAC file — 0 generic and 3 brand products.

What is the average price of Intra-Cellular Therapies, Inc drugs?

The average NADAC across Intra-Cellular Therapies, Inc's portfolio is $57.2228 per unit, ranging from $57.1998 to $57.2344.

What types of drugs does Intra-Cellular Therapies, Inc make?

Intra-Cellular Therapies, Inc makes drugs across 1 FDA pharmacologic class. The most common by NDC count are Atypical Antipsychotic (3).

Has Intra-Cellular Therapies, Inc had any drug recalls?

No FDA enforcement recalls are matched to Intra-Cellular Therapies, Inc in the openFDA feed.

How has Intra-Cellular Therapies, Inc's pricing changed recently?

Over the past 7 days, 1 Intra-Cellular Therapies, Inc product rose and 1 fell, with a portfolio-wide average change of +0.0%.

Drug Portfolio

3 drugs total, 3 shown

WatchDrug ↕Price 7d Change ↕
CAPLYTA 10.5 MG CAPSULE
lumateperone
$57.2344
per EA
+0.03%
CAPLYTA 42 MG CAPSULE
lumateperone
$57.2341
per EA
-0.01%
CAPLYTA 21 MG CAPSULE
lumateperone
$57.1998
per EA
0.00%